Castle Biosciences Cash Flow Statement
NASDAQ: CSTLHealth CareMedical SpecialitiesUSD
At close: Oct 9, 4:00 PM ET · Delayed 15 min
Castle Biosciences free cash flow
In fiscal 2025, Castle Biosciences generated $64.3 million of operating cash flow and spent $36.0 million on capital expenditures. That left free cash flow of $28.3 million, a free-cash-flow margin of 8.2% of revenue. Free cash flow was down 22.5% from the prior year's $36.5 million.
Summary generated from market data by MetaCap's automated system. Methodology
Castle Biosciences cash flow statement (annual)
| Fiscal year (USD) | FY 20252025-12-31 | FY 20242024-12-31 | FY 20232023-12-31 | FY 20222022-12-31 | FY 20212021-12-31 | FY 20202020-12-31 | FY 20192019-12-31 | FY 20182018-12-31 |
|---|---|---|---|---|---|---|---|---|
| Net Income | -24.16M | 18.25M | -57.47M | -67.14M | -31.29M | -10.28M | 5.28M | -6.37M |
| Net Income growth (YoY) | -232.41% | — | — | — | — | -294.88% | — | — |
| Depreciation & Amortization | 40.77M | 16.00M | 12.33M | 10.54M | 3.41M | 472.00K | 354.00K | 287.00K |
| Stock-Based Compensation | 45.89M | 50.32M | 51.22M | 36.32M | 21.74M | 8.31M | 1.25M | 294.00K |
| Change in Working Capital | 7.45M | -16.95M | -13.52M | -6.70M | -13.29M | 8.07M | -779.00K | -8.78M |
| Operating Cash Flow | 64.35M | 64.87M | -5.63M | -41.66M | -18.98M | 9.87M | 7.01M | -12.29M |
| Capital Expenditures | -36.02M | -28.33M | -13.62M | -5.63M | -3.48M | -4.75M | -937.00K | -277.00K |
| Investing Cash Flow | -60.37M | -50.14M | -16.18M | -166.54M | -66.66M | -4.75M | -937.00K | -277.00K |
| Debt Issued | 0 | 10.00M | 0 | 0 | — | — | — | — |
| Financing Cash Flow | -6.96M | 6.14M | -2.30M | 1.51M | 5.42M | 305.89M | 88.29M | 15.84M |
| Net Change in Cash | -2.98M | 20.87M | -24.11M | -206.69M | -80.22M | 311.01M | 94.37M | 3.27M |
| Free Cash Flow | 28.33M | 36.54M | -19.25M | -47.29M | -22.47M | 5.11M | 6.08M | -12.57M |
This table shows 8 annual periods of Castle Biosciences's cash flow statement, from FY 2025 back to FY 2018, across 11 line items including net income, depreciation & amortization, stock-based compensation. Values in USD; B = billions, M = millions. Fiscal periods follow CSTL's reporting calendar. What is a cash flow statement?